Korea’s nonlisted pharmaceutical companies saw their earnings surge 38 percent on-year in 2010 thanks to growing demand, a report showed recently.
The combined sales of 54 firms unlisted on the main bourse posted a 10 percent rise last year, with their operating incomes up 17 percent, according to the report compiled by Yakup Shinmoon (www.yakup.com).
According to the report, these nonlis...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.